Filter
1325
Text search:
HIV
epidemics
Featured
121
333
Language
Document type
858
203
114
53
49
17
12
8
8
1
1
1
Countries / Regions
63
42
36
35
32
31
27
26
25
24
23
22
22
21
21
19
18
18
17
16
14
14
14
13
12
11
11
11
10
10
9
9
9
8
7
6
6
6
6
6
6
5
5
5
4
4
4
3
3
3
3
3
3
3
2
2
2
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Category
442
105
66
47
46
15
7
1
Toolboxes
334
133
87
52
38
35
26
23
22
21
20
19
18
16
15
14
10
9
9
7
7
2
1
Prevention, early diagnosis, and effective treatment are essential for the control and elimination of Neisseria gonorrhoeae as a public health problem. Currently, in Latin America and the Caribbean, treatment for gonorrhea infection is largely empiric and based on clinical diagnosis. In the Americas
...
Development of one or more vaccines for Neisseria gonorrhoeae is an important objective for sexual and reproductive health worldwide, and for the fight against antimicrobial resistance.
WHO preferred product characteristics (PPCs) provide strategic guidance as to WHO’s preferences for new vacci
...
Policy Brief. More languages available here https://apps.who.int/iris/handle/10665/179517
Sixth edition
2007
Department of AIDS Control
Ministry of Health & Family Welfare
National Tuberculosis and Leprosy Conrol Programme
6th edition
TB remains one of the world’s deadliest infectious diseases, second only to COVID-19, and drug-resistant TB strains are still a major concern. In the fight against TB, urgent investment is critical, especially in the context of the ongoing pandemic.
